vs
Side-by-side financial comparison of INSEEGO CORP. (INSG) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
INSEEGO CORP. is the larger business by last-quarter revenue ($48.4M vs $39.6M, roughly 1.2× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 1.0%, a 34.9% gap on every dollar of revenue. On growth, INSEEGO CORP. posted the faster year-over-year revenue change (0.6% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $11.6M). Over the past eight quarters, INSEEGO CORP.'s revenue compounded faster (13.6% CAGR vs -15.0%).
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
INSG vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $39.6M |
| Net Profit | $469.0K | $14.2M |
| Gross Margin | 42.2% | 73.1% |
| Operating Margin | 2.7% | 32.5% |
| Net Margin | 1.0% | 35.9% |
| Revenue YoY | 0.6% | -10.9% |
| Net Profit YoY | 182.9% | 117.2% |
| EPS (diluted) | $-0.02 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $39.6M | ||
| Q3 25 | $45.9M | $43.4M | ||
| Q2 25 | $40.2M | $43.4M | ||
| Q1 25 | $31.7M | $47.3M | ||
| Q4 24 | $48.1M | $44.4M | ||
| Q3 24 | $54.0M | $53.1M | ||
| Q2 24 | $51.6M | $53.1M | ||
| Q1 24 | $37.5M | $54.8M |
| Q4 25 | $469.0K | $14.2M | ||
| Q3 25 | $1.4M | $12.8M | ||
| Q2 25 | $507.0K | $2.5M | ||
| Q1 25 | $-1.6M | $21.5M | ||
| Q4 24 | $-566.0K | $6.5M | ||
| Q3 24 | $9.0M | $2.8M | ||
| Q2 24 | $624.0K | $18.5M | ||
| Q1 24 | $-4.5M | $18.8M |
| Q4 25 | 42.2% | 73.1% | ||
| Q3 25 | 41.6% | 70.6% | ||
| Q2 25 | 41.1% | 69.2% | ||
| Q1 25 | 47.3% | 79.7% | ||
| Q4 24 | 37.3% | 76.3% | ||
| Q3 24 | 34.8% | 81.5% | ||
| Q2 24 | 36.4% | 74.2% | ||
| Q1 24 | 35.3% | 72.1% |
| Q4 25 | 2.7% | 32.5% | ||
| Q3 25 | 4.7% | 36.6% | ||
| Q2 25 | 3.2% | 33.6% | ||
| Q1 25 | -1.3% | 51.1% | ||
| Q4 24 | 3.7% | 10.6% | ||
| Q3 24 | 1.9% | 26.1% | ||
| Q2 24 | 3.6% | 51.4% | ||
| Q1 24 | -7.9% | 44.6% |
| Q4 25 | 1.0% | 35.9% | ||
| Q3 25 | 3.1% | 29.6% | ||
| Q2 25 | 1.3% | 5.7% | ||
| Q1 25 | -5.0% | 45.4% | ||
| Q4 24 | -1.2% | 14.7% | ||
| Q3 24 | 16.6% | 5.3% | ||
| Q2 24 | 1.2% | 34.8% | ||
| Q1 24 | -11.9% | 34.2% |
| Q4 25 | $-0.02 | $0.15 | ||
| Q3 25 | $0.03 | $0.12 | ||
| Q2 25 | $-0.03 | $0.02 | ||
| Q1 25 | $-0.16 | $0.21 | ||
| Q4 24 | $0.62 | $0.05 | ||
| Q3 24 | $-0.06 | $0.03 | ||
| Q2 24 | $-0.02 | $0.20 | ||
| Q1 24 | $-0.44 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $-4.0M | $248.3M |
| Total Assets | $93.8M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.9M | $164.1M | ||
| Q3 25 | $14.6M | $127.4M | ||
| Q2 25 | $13.2M | $152.7M | ||
| Q1 25 | $35.1M | $132.1M | ||
| Q4 24 | $39.6M | $125.0M | ||
| Q3 24 | $12.0M | $137.4M | ||
| Q2 24 | $49.0M | — | ||
| Q1 24 | $12.3M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-4.0M | $248.3M | ||
| Q3 25 | $-7.7M | $248.0M | ||
| Q2 25 | $-10.5M | $244.6M | ||
| Q1 25 | $-13.0M | $226.4M | ||
| Q4 24 | $-12.9M | $195.1M | ||
| Q3 24 | $-85.1M | $205.0M | ||
| Q2 24 | $-101.8M | $8.8M | ||
| Q1 24 | $-105.6M | $9.0M |
| Q4 25 | $93.8M | $380.4M | ||
| Q3 25 | $85.8M | $321.4M | ||
| Q2 25 | $83.1M | $315.3M | ||
| Q1 25 | $93.0M | $284.6M | ||
| Q4 24 | $100.0M | $266.1M | ||
| Q3 24 | $113.4M | $296.5M | ||
| Q2 24 | $149.6M | $19.5M | ||
| Q1 24 | $122.1M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.0M | $52.0M |
| Free Cash FlowOCF − Capex | $11.6M | $51.2M |
| FCF MarginFCF / Revenue | 24.0% | 129.3% |
| Capex IntensityCapex / Revenue | 0.7% | 2.0% |
| Cash ConversionOCF / Net Profit | 25.50× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $6.5M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.0M | $52.0M | ||
| Q3 25 | $3.2M | $-20.9M | ||
| Q2 25 | $-4.5M | $-8.3M | ||
| Q1 25 | $-3.5M | $1.9M | ||
| Q4 24 | $-14.2M | $-7.3M | ||
| Q3 24 | $14.8M | $5.0M | ||
| Q2 24 | $27.6M | $19.2M | ||
| Q1 24 | $5.2M | $3.7M |
| Q4 25 | $11.6M | $51.2M | ||
| Q3 25 | $3.1M | $-20.9M | ||
| Q2 25 | $-4.7M | $-8.6M | ||
| Q1 25 | $-3.5M | $1.7M | ||
| Q4 24 | $-14.3M | $-7.9M | ||
| Q3 24 | $14.8M | $4.6M | ||
| Q2 24 | $27.6M | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | 24.0% | 129.3% | ||
| Q3 25 | 6.7% | -48.3% | ||
| Q2 25 | -11.6% | -19.9% | ||
| Q1 25 | -11.0% | 3.5% | ||
| Q4 24 | -29.7% | -17.8% | ||
| Q3 24 | 27.4% | 8.7% | ||
| Q2 24 | 53.5% | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | 0.7% | 2.0% | ||
| Q3 25 | 0.2% | 0.1% | ||
| Q2 25 | 0.5% | 0.7% | ||
| Q1 25 | 0.1% | 0.5% | ||
| Q4 24 | 0.1% | 1.3% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 1.6% | ||
| Q1 24 | 0.0% | 1.3% |
| Q4 25 | 25.50× | 3.66× | ||
| Q3 25 | 2.22× | -1.63× | ||
| Q2 25 | -8.81× | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 1.65× | 1.77× | ||
| Q2 24 | 44.31× | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INSG
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
